Staphylococcus schleiferi Treatment Guidelines

Antimicrobial Therapy

For uncomplicated skin and soft tissue infections, the treatment duration is 5-10 days 1
For complicated or hospitalized infections, the treatment duration is 7-14 days depending on clinical response 2
Vancomycin 30-60 mg/kg/day IV divided every 6-12 hours is recommended for empiric therapy in mecA-positive S. schleiferi infections 1, 3, 2
Linezolid 600 mg IV/PO every 12 hours is an alternative for empiric therapy in mecA-positive S. schleiferi infections 1, 2
Daptomycin 4 mg/kg/dose IV daily is recommended for skin/soft tissue infections in mecA-positive S. schleiferi infections 1
For bacteremia, vancomycin 30-60 mg/kg/day IV or daptomycin 6 mg/kg/dose IV daily is recommended for a minimum of 2 weeks 3
For complicated bacteremia, vancomycin or daptomycin 6-10 mg/kg/dose IV daily is recommended for 4-6 weeks 3

Vancomycin dosing for pediatric patients should follow standard institutional protocols for MRSA coverage 2, 4
Clindamycin 10-13 mg/kg/dose IV every 6-8 hours is recommended for pediatric patients with S. schleiferi infections, only if local resistance is <10% 2, 4
Linezolid 10 mg/kg/dose PO/IV every 8 hours is recommended for children <12 years, and 600 mg every 12 hours for ≥12 years 2
Tetracyclines should be avoided in children <8 years of age 2, 5

Source control is essential, including incision and drainage for abscesses and purulent collections 1
Debride necrotic tissue in complicated infections 3
Monitor clinical response within 48-72 hours of initiating therapy and adjust antibiotics based on culture and susceptibility results 2
For vancomycin, monitor trough levels targeting 15-20 mcg/mL for serious infections 1

Regular handwashing with soap and water or alcohol-based hand sanitizer is recommended to prevent recurrence 2, 5
Environmental hygiene focusing on high-touch surfaces is recommended to prevent recurrence 2, 5
Consider decolonization strategies (mupirocin ± chlorhexidine) for recurrent infections 3, 2